The interaction of PD-1/PD-L1 in the tumor microenvironment can induce resistance to cytotoxic T cell (CD8+)-mediated elimination of tumor cells by promoting cancer development and progression [26,27]. The gene discussed is PDCD1; the disease is neoplasm.